Reneo Pharmaceuticals to Participate in SVB Leerink Virtual Global Healthcare Conference
IRVINE, Calif., Feb. 02, 2022 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical…
News
VBL Therapeutics to Participate in the Guggenheim Oncology Conference and the 2022 BIO CEO & Investor Conference
TEL AVIV, Israel and NEW YORK, Feb. 02, 2022 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq:…
Bluejay Therapeutics Announces the Appointment of Nancy Shulman, M.D., as Chief Medical Officer
SAN MATEO, Calif., Feb. 02, 2022 (GLOBE NEWSWIRE) — Bluejay Therapeutics, a private biopharmaceutical company…
Achieve Life Sciences Announces Participation in February Investor Conferences
SEATTLE and VANCOUVER, British Columbia, Feb. 02, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….
Fate Therapeutics to Present at Upcoming February Investor Conferences
SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…
Bolt Biotherapeutics to Participate in Upcoming February Conferences
REDWOOD CITY, Calif., Feb. 02, 2022 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage…
PDS Biotech Announces Preliminary Efficacy Achievement in VERSATILE-002 Phase 2 Trial of PDS0101 in Combination With KEYTRUDA® (pembrolizumab) in Advanced Head and Neck Cancer
Achievement of initial efficacy milestone allows full enrollment of checkpoint inhibitor naïve cohort FLORHAM PARK,…
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
CAMBRIDGE, Mass., Feb. 02, 2022 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled…
Brickell Biotech Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting Autoimmune and Inflammatory Diseases from Carna Biosciences
Lead STING inhibitor candidate, BBI-10, demonstrated dose-dependent cytokine reduction in nonclinical in vitro and in…
Avicanna Provides Q4-2021 Results and Corporate Highlights as well as Fiscal 2022 Guidance
Projected revenue of $9M for fiscal 2022 through its Canadian and global operations, including the…
Medicenna to Announce Third Quarter Fiscal 2022 Financial Results and Operational Highlights on Wednesday, February 9, 2022
TORONTO and HOUSTON, Feb. 02, 2022 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the…
Clearside Biomedical’s Suprachoroidal Injection Platform to be Featured at the Angiogenesis, Exudation, and Degeneration 2022 Virtual Conference on February 12, 2022
Clearside’s suprachoroidal space (SCS®) injection platform to be featured at top medical meeting and also…
Notified Expands Strategic Partnership with Nasdaq to Simplify ESG Data Management and Reporting for Customers
Agreement allows Notified to offer Nasdaq OneReport software to its Investor Relations, Public Relations, and…
Avid Unveils Avid NEXIS | EDGE to Power Post Production Workflows from Anywhere
Unique innovations enable content creation teams to collaborate without compromise and work from anywhere with…
LogMeIn Rebrands as GoTo with a New Application Combining Support and Communications Solutions, New Products, and a New Partner Network
Launch follows strong growth and deepened commitment to global expansion and partners MUNICH, Germany, Feb….
Newly Rebranded Company, GoTo, Disrupts the IT Support Landscape with GoTo Resolve, a New, Modern IT Management Product Built for Today’s Flexible Workforce
GoTo Resolve brings first to market zero trust architecture as well as conversational IT support…
LogMeIn Rebrands as GoTo with a New Application Combining Support and Communications Solutions, New Products, and a New Partner Network
Launch follows strong growth and deepened commitment to global expansion and partners MEXICO CITY, Feb….
Synchronoss Reports Accelerated Cloud Subscriber Growth in the Fourth Quarter of 2021
Increased Adoption from New and Existing Customers Drove 18% Year-Over-Year Subscriber Growth for Synchronoss Cloud…
LogMeIn Rebrands as GoTo with a New Application Combining Support and Communications Solutions, New Products, and a New Partner Network
Launch follows strong growth and deepened commitment to global expansion and partners SÃO PAULO, Brazil,…
LogMeIn Rebrands as GoTo with a New Application Combining Support and Communications Solutions, New Products, and a New Partner Network
Launch follows strong growth and deepened commitment to global expansion and partners SYDNEY, Australia, Feb….